PMID- 38258297 OWN - NLM STAT- Publisher LR - 20240123 IS - 1940-2465 (Electronic) IS - 1066-8969 (Linking) DP - 2024 Jan 22 TI - Mechanistic Target of Rapamycin Kinase is a Common Convergent Pathway to Renal Neoplasia: A Contemporary Review. PG - 10668969231219653 LID - 10.1177/10668969231219653 [doi] AB - Mechanistic target of rapamycin kinase (mTOR) is a member of the phosphatidylinositol-3-hydroxide kinase (PI3 K)-related protein kinase family that functions as a central regulator of cell growth, metabolism, proliferation, and survival. The role of the TSC-mTOR signaling pathway in kidney tumors has been implicated in some hamartoma syndromes; however, with the advent and wide utilization of molecular studies, a growing number of kidney tumors have been linked to somatic or germline mutations involving genes that encode for this pathway, including eosinophilic solid and cystic renal cell carcinoma, low-grade oncocytic tumor, eosinophilic vacuolated tumor, renal cell carcinoma with fibromyomatous stroma and angiomyolipoma, among others. Herein, we review the contemporary developments of mTOR pathway-related renal neoplasia, focusing on the clinicopathologic features of the tumor entities. FAU - Alruwaii, Zainab I AU - Alruwaii ZI AD - Department of Pathology and Laboratory Medicine, King Fahad Specialist Hospital, Dammam, KSA. FAU - Williamson, Sean R AU - Williamson SR AUID- ORCID: 0000-0002-3898-1460 AD - Pathology and Laboratory Medicine Institute, The Cleveland Clinic, Cleveland, OH, USA. FAU - Al-Obaidy, Khaleel I AU - Al-Obaidy KI AUID- ORCID: 0000-0001-9890-8751 AD - Department of Pathology and Laboratory Medicine, Henry Ford Health, Detroit, MI, USA. AD - Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, MI, USA. LA - eng PT - Journal Article DEP - 20240122 PL - United States TA - Int J Surg Pathol JT - International journal of surgical pathology JID - 9314927 SB - IM OTO - NOTNLM OT - kidney, tuberous sclerosis, MTOR, renal cell, tumor, carcinoma COIS- Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. EDAT- 2024/01/23 06:43 MHDA- 2024/01/23 06:43 CRDT- 2024/01/23 02:52 PHST- 2024/01/23 06:43 [medline] PHST- 2024/01/23 06:43 [pubmed] PHST- 2024/01/23 02:52 [entrez] AID - 10.1177/10668969231219653 [doi] PST - aheadofprint SO - Int J Surg Pathol. 2024 Jan 22:10668969231219653. doi: 10.1177/10668969231219653.